U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Drug Topics: An Overview of Pharmacovigilance in the Center for Drug Evaluation and Research (CDER) – March 26, 2019
  1. About FDA

FDA Drug Topics: An Overview of Pharmacovigilance in the Center for Drug Evaluation and Research (CDER) – March 26, 2019

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!

On Tuesday, March 26, 2019, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: An Overview of Pharmacovigilance in the Center for Drug Evaluation and Research (CDER). This webinar featured Kim Swank, PharmD, Safety Evaluator in the Office of Surveillance and Epidemiology’s Division of Pharmacovigilance II and gave an overview of how the FDA conducts pharmacovigilance activities, detect safety signals, and communicates safety findings.

Download Presentation Slides: An Overview of Pharmacovigilance in the Center for Drug Evaluation and Research (PDF - 2MB)

Activity Outline and Continuing Education Information: An Overview of Pharmacovigilance in the Center for Drug Evaluation and Research (PDF - 196KB)


If you have never attended an Adobe Connect meeting before:

Test your connection: Adobe Connect Diagnostic Test

Get a quick overview: Discover Adobe Connect Solutions

Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.